Drs. Nicholas Farber, Mrinali Gupta, and Yoshihiro Yonekawa join for a journal club style discussion of three recent publications in high-impact ophthalmology journals.
ALIGN study, Retinal displacement after RRD Pneumatic versus PPV
RRDs during COVID-19
Anti-VEGF versus laser for ROP
Relevant Financial Disclosures:
Dr. Sridhar is a consultant for Alcon, Allergan, Dorc, Genentech, and Regeneron. Dr. Yonekawa is a consultant for Alcon. Dr. Gupta is a consultant for Alcon, Allergan, Alimera, and Zeiss. Dr. Farber has no disclosures.
Release: January 27, 2022; expires January 27, 2025
Reviewers: D. Wilkin Parke III, MD
Disclosures: The physician reviewers and Academy staff report no relevant financial disclosures.
Learning Objective: Upon completion of this episode, the listener should be able to describe evolving standards of care for the management of vitreoretinal disorders or the outcomes from recent research and how these impact patient care decisions.
Audience: This activity is intended for retina subspecialists and comprehensive ophthalmologists.
Accreditation: The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Academy of Ophthalmology designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits.TM Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hardware/Software Requirements: This learning activity requires a current web browser and speaker or headset capable of playing streaming audio.